Qiagen N.V.
News
Declining Stock and Decent Financials: Is The Market Wrong About Qiagen N.V. (NYSE:QGEN)?
Simply Wall St Qiagen (NYSE:QGEN) has had a rough week with its share price down 2.7%. But if you pay close attention, you might find...\n more…
Qiagen (NYSE:QGEN) Given Average Recommendation of "Moderate Buy" by Brokerages
Ticker Report Shares of Qiagen (NYSE:QGEN - Get Free Report) have been given an average rating of "Moderate Buy" by the nine brokerages that are currently covering the firm, Marketbeat.com reports. Three...\n more…
QIAGEN, Lilly to develop Alzheimer's risk detection test
Seeking Alpha - Healthcare QIAGEN, Lilly to develop Alzheimer's risk detection test...\n more…
QIAGEN and Lilly collaborate to support development of a QIAstat-Dx IVD panel that identifies patients at risk for developing Alzheimer's disease
Globe Newswire QIAGEN to develop the first QIAstat-Dx IVD panel for neurodegenerative applications // New QIAstat-Dx panel to identify APOE genotypes, one of many factors considered in the diagnosis of patients...\n more…
QIAGEN N.V. announces conversion price of new net share settled convertible bonds
Globe Newswire NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION INTO OR IN THE UNITED STATES, CANADA, AUSTRALIA, JAPAN, SOUTH AFRICA OR ANY OTHER STATE OR JURISDICTION IN WHICH SUCH RELEASE, PUBLICATION OR DISTRIBUTION...\n more…